Manatuck Hill Partners’s Strata Critical Medical Inc SRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-100,000
Closed -$506K 105
2025
Q3
$506K Buy
+100,000
New +$442K 0.17% 88
2025
Q1
Sell
-600,000
Closed -$2.55M 99
2024
Q4
$2.55M Buy
+600,000
New +$2.28M 1.04% 29

Other funds holding SRTA

Manatuck Hill Partners's SRTA Position: Q4 2025 in Review

Manatuck Hill Partners sold out of Strata Critical Medical Inc (SRTA) in Q4 2025, closing a stake of 100,000 shares — an estimated $506K sold.

Manatuck Hill Partners first reported a position in SRTA in Q4 2024 and held it in 2 quarters. The position peaked at $2.55M in Q4 2024. 125 funds tracked by Wall St. Rank hold SRTA as of Q4 2025.

  • Manatuck Hill Partners reported no remaining Strata Critical Medical Inc position as of Q4 2025 after selling out during the quarter.
  • Manatuck Hill Partners sold 100,000 Strata Critical Medical Inc shares in Q4 2025, an estimated $506K.
  • Manatuck Hill Partners first reported a position in Strata Critical Medical Inc in Q4 2024 and held it in 2 quarters.
  • Manatuck Hill Partners's Strata Critical Medical Inc position peaked at $2.55M in Q4 2024.
  • 125 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q4 2025.

Based on Manatuck Hill Partners's 13F filing for Q4 2025, filed 17 Feb 2026.